The Business of Regenerative Medicine is organized collaboratively by CCRM, the Harvard Stem Cell Institute, Case Western Reserve University and the Parker H. Petit Institute for Bioengineering & Bioscience at Georgia Tech. The course was developed at Case Western Reserve University by Professor Arnold Caplan. The course, now in its 10th year, educates graduate students and executives alike on the key economic and business issues in the field of regenerative medicine and cell therapies. You can view last year's program, hosted by Harvard Stem Cell Institute, here. For more details, check out Signals' blog course highlights on the Business of Regenerative Medicine: Cells at Work hosted in 2015 by Georgia Tech, andthe Business of Regenerative Medicine: New Therapies, New Models hosted in 2014 by CCRM.